Birthplace of Amersham s MegaBace Fades, And Piscataway Rises, Under GE Healthcare | GenomeWeb

The Sunnyvale, Calif., facility that served as the birthplace of Amersham Bioscience’s MegaBace DNA-sequencing technology and other genomics technologies and research is apparently being downsized as part of Amersham’s continued integration into General Electric Healthcare, BioCommerce Week has learned.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.